HeraMED Ltd. (AU:HMD) has released an update.
HeraMED Ltd has reported significant progress in its third-quarter 2024 results, with a record number of active and registered users on its HeraCARE platform, boosted by a successful launch at Broward Health in Florida. The company has also secured a $3.1 million investment to accelerate its commercial deployments and strategic partnerships aimed at integrating HeraCARE into major health systems across the US, Europe, and Australia. With a focus on reducing costs and expanding its user base, HeraMED is poised for sustainable growth in the digital maternity care sector.
For further insights into AU:HMD stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
